Oncology-trained physician turned biotechnology leader with 20 years of strong cross-functional operations and strategic planning experience across all stages of drug development and commercialization at blue-chip (Pfizer, Merck, Genentech) and startup biopharma companies. Expertise in management, development, commercialization and global launch of transformative therapies for rare, severe and debilitating diseases.